Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorPinho, Elizabethen_US
dc.date.accessioned2012-06-15T20:29:51Z
dc.date.issued2001en_US
dc.identifier.citationThe Story of RU-486 in the United States (2001 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8889480
dc.description.abstractIn this paper, I will navigate you through the fascinating odyssey of RU-486 from its initial development in France to its official entry into the U.S. pharmaceutical market to the post-approval strife in which it is now embroiled. While many assumed that the FDA’s approval of RU-486 on September 28, 2000 would mark the final chapter in the story of the drug’s acceptance as an early pregnancy termination procedure, it actually marked the beginning of a new chapter, which ignited congressional efforts to stymie, or even abort, the growth of this chemical alternative to surgical abortion in the United States. As a result of these congressional efforts, the last chapter in the story of RU-486 remains to be written.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectRU-486en
dc.subjectabortion pillen
dc.subjectFDAen
dc.titleThe Story of RU-486 in the United Statesen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-06-15T20:29:51Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record